Peptimimesis
Peptimimesis's email is contact@peptimimesis.com
.
PeptiMimesis is a strategic partner in the design, the discovery and the early development of transmembrane therapeutic peptides. Our innovative approach enables the identification of peptidomimetic candidates interfering with the hetero- and/or the homodimerization of target receptors. PeptiMimesis will develop its pipeline against key targets in the fields of oncology, immuno-oncology and immune disease and is open to initiate collaboration with pharma partners on receptors of interest.
View Top Employees for Peptimimesis
|
Website | peptimimesis.com |
|
Industry | Biotechnology |
|
Employees | 2 |
|
HQ | 850 Boulevard Sébastien Brant |
|
contact@peptimimesis.com | |
|
Funding | 2,151,623 USD |
|
Competitors | Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences, |
|
|
Website | peptimimesis.com |
|
|
Industry | Biotechnology |
|
|
Employees | 2 |
|
linkedin.com/company/peptimimesis | |
|
|
HQ | 850 Boulevard Sébastien Brant |
|
|
contact@peptimimesis.com | |
|
|
Funding | 2,151,623 USD |
Top Competitors for Peptimimesis
Peptimimesis Questions
Where are Peptimimesis's headquarters?
Peptimimesis's headquarters are in 850 Boulevard Sébastien Brant
What is Peptimimesis's official website?
Peptimimesis's website is peptimimesis.com
How many employees are working in Peptimimesis right now?
Peptimimesis has
2 employees.
View the Email and Phone Numbers for all 2 working at Peptimimesis.
What is Peptimimesis's industry?
Peptimimesis's industry is
Biotechnology
Who are Peptimimesis's top competitors?
Peptimimesis's top competitors are
Roche
,
Agilent Technologies
,
Amgen
,
Genentech
,
Eurofins
,
Gilead Sciences
What is Peptimimesis's email address?
Peptimimesis's email address is contact@peptimimesis.com
What are Peptimimesis's categories?
Peptimimesis's categories are Biotechnology, Medical, Pharmaceutical, Therapeutics
What is Peptimimesis's funding?
Peptimimesis's funding is 2,151,623 USD
What is Peptimimesis's current status?
Peptimimesis's current status is operating
